Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460462
Filing Date
2012-11-08
Accepted
2012-11-08 16:16:45
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398882d10q.htm 10-Q 584211
2 EX-31.1 d398882dex311.htm EX-31.1 6080
3 EX-31.2 d398882dex312.htm EX-31.2 5854
4 EX-32.1 d398882dex321.htm EX-32.1 4432
  Complete submission text file 0001193125-12-460462.txt   3422094

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zlcs-20120930.xml EX-101.INS 395223
6 XBRL TAXONOMY EXTENSION SCHEMA zlcs-20120930.xsd EX-101.SCH 31588
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zlcs-20120930_cal.xml EX-101.CAL 55491
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zlcs-20120930_def.xml EX-101.DEF 88205
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlcs-20120930_lab.xml EX-101.LAB 273694
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlcs-20120930_pre.xml EX-101.PRE 204553
Mailing Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142 617-301-7000
Zalicus Inc. (Filer) CIK: 0001135906 (see all company filings)

EIN.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51171 | Film No.: 121190279
SIC: 2834 Pharmaceutical Preparations